Research Progress on Rosacea and Cutaneous Co-Morbidities and Systemic Diseases

Shan He; Hao Feng; Hua Tang; Yangying Liao

doi:10.54097/xxht2920

Authors

Shan He
Hao Feng
Hua Tang
Yangying Liao

DOI:

https://doi.org/10.54097/xxht2920

Keywords:

Rosacea, Co-morbidities, Systemic Diseases

Abstract

Rosacea can be associated with a variety of cutaneous co-morbidities. In addition to skin lesions, rosacea is associated with systemic diseases such as cardiovascular and metabolic diseases, respiratory diseases, gastrointestinal diseases and mental health problems, as well as with the development of some malignant tumors. In addition, ocular disease is a frequent co-morbidity of rosacea. This article reviews recent studies on co-morbidities and systemic diseases of rosacea, which may help to improve the prognosis and quality of life of patients.

Downloads

Download data is not yet available.

References

[1] Geng R S Q, Bourkas A N, Mufti A, et al. Rosacea: Pathogenesis and Therapeutic Correlates[J]. Journal of Cutaneous Medicine and Surgery, 2024, 28(2): 178-89. http:// dx. doi.org/10.1177/12034754241229365.

[2] Wollina U. Is rosacea a systemic disease?[J]. Clinics in Dermatology, 2019, 37(6): 629-35. http://dx.doi. org/10. 1016/j.clindermatol.2019.07.032.

[3] Yang F, Wang L, Shucheng H, et al. Differences in clinical characteristics of rosacea across age groups: A retrospective study of 840 female patients[J]. Journal of Cosmetic Dermatology, 2023, 22(3): 949-57. http://dx.doi.org/ 10.1111/ jocd.15470.

[4] Zander N, Sommer R, Schäfer I, et al. Epidemiology and dermatological comorbidity of seborrhoeic dermatitis: population-based study in 161 269 employees[J]. Br J Dermatol, 2019, 181(4): 743-8. http://dx.doi.org/ 10.1111/ bjd. 17826.

[5] Sharma A N, Kincaid C M, Mesinkovska N A. The Burden of Melasma: Race, Ethnicity, and Comorbidities[J]. J Drugs Dermatol, 2024, 23(8): 691-3. http://dx.doi. org/10. 36849/ jdd.8233.

[6] Konisky H, Balazic E, Jaller J A, et al. Tranexamic acid in melasma: A focused review on drug administration routes[J]. Journal of Cosmetic Dermatology, 2023, 22(4): 1197-1206. http:// dx.doi.org/10.1111/jocd.15589.

[7] von Stebut J, Mallach M, Schneider-Burrus S, et al. Rosacea is strongly associated with melanoma in Caucasians[J]. Scientific Reports, 2024, 14(1): 11949. http://dx.doi.org/ 10.1038/ s41598-024-62552-8.

[8] Cho S I, Lee H, Cho S. Risk of Skin Cancer and Actinic Keratosis in Patients with Rosacea: A Nationwide Population-based Cohort Study[J]. Acta Derm Venereol, 2022, 102: adv00803. http://dx.doi.org/10.2340/actadv.v102.2563.

[9] Caf N, Özkök Akbulut T, Can M M, et al. Evaluation of subclinical atherosclerosis in rosacea patients by flow-mediated dilatation method[J]. Journal of Cosmetic Dermatology, 2023, 22(3): 1001-10. http://dx.doi.org/ 10. 1111/ jocd.15492.

[10] Ertekin S S, Koku Aksu A E, Koçyiğit A, et al. Carotid intima-media thickness and serum proinflammatory cytokine levels in rosacea patients without cardiovascular risk factors[J]. Dermatologic Therapy, 2021, 34(1): e14733. http://dx.doi. org/10. 1111/dth.14733.

[11] Tsai T Y, Chiang Y Y, Huang Y C. Cardiovascular Risk and Comorbidities in Patients with Rosacea: A Systematic Review and Meta-analysis[J]. Acta Derm Venereol, 2020, 100(17): adv00300. http://dx.doi.org/10.2340/00015555-3668.

[12] Zhang J, Yan Y, Jiang P, et al. Association between rosacea and cardiovascular disease: A systematic review and meta-analysis[J]. Journal of Cosmetic Dermatology, 2021, 20(9): 2715-22. http://dx.doi.org/10.1111/jocd.13884.

[13] Chen Q, Shi X, Tang Y, et al. Association between rosacea and cardiometabolic disease: A systematic review and meta-analysis[J]. J Am Acad Dermatol, 2020, 83(5): 1331-40. http://dx.doi.org/10.1016/j.jaad.2020.04.113.

[14] Searle T, Al-Niaimi F, Ali F R. Rosacea and the cardiovascular system[J]. Journal of Cosmetic Dermatology, 2020, 19(9): 2182-7. http://dx.doi.org/10.1111/jocd.13587.

[15] Yuan X, Yin D. Association between rosacea and smoking: A systematic review and meta-analysis[J]. Dermatologic Therapy, 2021, 34(2): e14747. http://dx.doi.org/10.1111/dth.14747.

[16] Sahin R B, Kilic F A, Hizli P, et al. Serum zinc-alpha-2 glycoprotein and insulin levels and their correlation with metabolic syndrome in patients with rosacea[J]. Journal of Cosmetic Dermatology, 2023, 22(2): 645-50. http://dx.doi.org/ 10. 1111/jocd.15447.

[17] Wang F Y, Chi C C. Rosacea, Germs, and Bowels: A Review on Gastrointestinal Comorbidities and Gut-Skin Axis of Rosacea[J]. Advances in Therapy, 2021, 38(3): 1415-24. http:// dx.doi.org/10.1007/s12325-021-01624-x.

[18] Shen S, Gao X, Song X, et al. Association between inflammatory bowel disease and rosacea: A bidirectional two-sample Mendelian randomization study[J]. J Am Acad Dermatol, 2024, 90(2): 401-3. http://dx. doi.org/ 10.1016/ j.jaad. 2023.10.003.

[19] Li M, He S X, He Y X, et al. Detecting potential causal relationship between inflammatory bowel disease and rosacea using bi-directional Mendelian randomization[J]. Scientific Reports, 2023, 13(1): 14910. http://dx.doi.org/ 10.1038/ s41598-023-42073-6.

[20] Wang F Y, Chi C C. Association of rosacea with inflammatory bowel disease: A MOOSE-compliant meta-analysis[J]. Medicine (Baltimore), 2019, 98(41): e16448. http:// dx. doi. org/ 10.1097/md.0000000000016448.

[21] Deng Z, Chen M, Zhao Z, et al. Whole genome sequencing identifies genetic variants associated with neurogenic inflammation in rosacea[J]. Nat Commun, 2023, 14(1): 3958. http:// dx.doi.org/10.1038/s41467-023-39761-2.

[22] Nowowiejska J, Baran A, Flisiak I. Lipid Alterations and Metabolism Disturbances in Selected Inflammatory Skin Diseases[J]. Int J Mol Sci, 2023, 24(8). http://dx. doi.org/ 10. 3390/ijms24087053.

[23] Woo Y R, Han Y J, Kim H S, et al. Updates on the Risk of Neuropsychiatric and Gastrointestinal Comorbidities in Rosacea and Its Possible Relationship with the Gut-Brain-Skin Axis[J]. Int J Mol Sci, 2020, 21(22). http://dx. doi.org/ 10. 3390/ijms21228427.

[24] Hung C T, Chiang C P, Chung C H, et al. Risk of psychiatric disorders in rosacea: A nationwide, population-based, cohort study in Taiwan[J]. Journal of Dermatology, 2019, 46(2): 110-6. http://dx.doi.org/10.1111/1346-8138.14705.

[25] Aksoy B, Ekiz Ö, Unal E, et al. Systemic comorbidities associated with rosacea: a multicentric retrospective observational study[J]. International Journal of Dermatology, 2019, 58(6): 722-8. http://dx.doi.org/10.1111/ijd.14353.

[26] Xerfan E M S, Andersen M L, Facina A S, et al. Rosacea, poor sleep quality, and obstructive sleep apnea: A commentary on potential interconnected features[J]. Journal of Cosmetic Dermatology, 2022, 21(10): 4234-6. http://dx.doi. org/10. 1111/ jocd.14806.

[27] Long J, Li J, Yuan X, et al. Potential association between rosacea and cancer: A study in a medical center in southern China[J]. Journal of Dermatology, 2019, 46(7): 570-6. http:// dx. doi.org/10.1111/1346-8138.14918.

[28] Tavassoli S, Wong N, Chan E. Ocular manifestations of rosacea: A clinical review[J]. Clin Exp Ophthalmol, 2021, 49 (2): 104-17. http://dx.doi.org/10.1111/ceo.13900.

[29] Vassileva S, Tanev I, Drenovska K. Rosacea: The eyes have it[J]. Clinics in Dermatology, 2023, 41(4): 528-36. http:// dx. doi.org/10.1016/j.clindermatol.2023.08.009.

[30] Wang F Y, Kang E Y, Liu C H, et al. Diabetic Patients With Rosacea Increase the Risks of Diabetic Macular Edema, Dry Eye Disease, Glaucoma, and Cataract[J]. Asia Pac J Ophthalmol (Phila), 2022, 11(6): 505-13. http://dx.doi.org/ 10. 1097/apo.0000000000000571.